MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

new research report 9th july, page-9

  1. 657 Posts.
    I looked at this 9 July report. A statement in the valuation section indicates that they may have done the currency conversion incorrectly:

    "If our earnings estimates are correct, then Metabolic Pharmaceuticals should turn profitable in FY08. Based on FY08 and FY09 earnings, a multiple of 30, and a discount rate of 40%, an indicated current valuation of $2.73 US, $1.97A per share is derived."

    If their valuation is $US 2.73 this is about $AUD (2.73/.72) = $AUD 3.79.

    Comments welcome

 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.